News & Articles

July 16, 2019

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing. 

July 16, 2019

Northway Biotechpharma has successfully implemented EU funded R&D project

Northway Biotechpharma would like to announce that UAB “Biotechpharma” has implemented the project “Creation of pegylated alpha 5 interferon”, financed according to the Operational Programme for The European Union Funds Investments for 2014-2020, Priority No. 1 “Promotion of scientific researches, experimental development and innovation”, No. J05-LVPA-K “Intelektas. Bendri mokslo – verslo projektai” invitation No 1. “Biotechpharma” has received 507.184,09 EUR support from the European Union Funds for implementation of the project.

May 20, 2019

Northway Biotechpharma is Changing its Management Structure and Appoints Giedrius Žunda as Chief Executive Officer

Biotechpharma UAB, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, is pleased to announce the appointment of Giedrius Žunda as Chief Executive Officer effective from 3 December 2018.

May 20, 2019

Northway Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L

Northway Biotechpharma will expand its existing manufacturing facility by adding a new line of bioreactors

March 08, 2019

Speed and Customized Support from Gene to GMP Manufacturing

Emerging, small and mid-sized biopharma companies with limited resources need contract development and manufacturing partners that can offer personalized support. By combining a range of integrated services supporting biologics throughout the life cycle, with the benefits of an expert, young and dynamic workforce, Biotechpharma UAB is uniquely positioned to support biopharma companies across the globe.

May 21, 2019

State-of-the-art Biologics Manufacturing in an Unexpected Location

Lithuania is a small country in the Baltic region of northeastern Europe bordering the southeastern shore of the Baltic Sea. While largely a service economy, Lithuania, which is a member of the European Union, has a substantial industrial sector that produces chemical products, plastics, machinery and appliances. Biotechpharma UAB, a rapidly growing contract development and manufacturing organization located in Vilnius, is adding biologic drug substances and drug products to the list of goods exported throughout Europe, North America, Asia and the Middle East.